<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642796</url>
  </required_header>
  <id_info>
    <org_study_id>2013/34</org_study_id>
    <nct_id>NCT02642796</nct_id>
  </id_info>
  <brief_title>Transcutaneous Nerve Stimulation for Post-operative Acute and Chronic Pain</brief_title>
  <official_title>Comparison of the Efficacy of Two Different Transcutaneous Electrical Nerve Stimulation Application Sites in Reducing Postoperative Pain After Hip Fracture Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mustafa Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mustafa Kemal University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study to assess the efficacy of two modes of transcutaneous electrical nerve
      stimulation (TENS) on relief of postoperative acute pain after hip fracture surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients underwent undergo fractured hip surgery will be distributed into three groups
      with respect to the mode of postoperative analgesia applied: Group I (control): PCA only;
      group II: PCA plus lumbar plexus &amp; sciatic nerve TENS (LS-TENS); group III: PCA plus surgical
      wound TENS (SW-TENS). TENS will be applied every 2 hours for 30-40 minutes during 48 hours
      postoperatively. Visual analogue score (VAS), Ramsey sedation scores, frequencies of PCA
      demand and counts of PCA delivery, as well as total analgesic consumption will be noted and
      compared between groups at various time intervals.

      Visual analog scale (VAS) will be applied at 2 months postoperatively VAS and Mcgill pain
      questionnaire will be applied at the 6th and 24th months of the surgery to assess acute and
      chronic pain in the study population and the differences among groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2013</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>48 h postoperatively</time_frame>
    <description>Postoperative pain intensity is assessed using VAS for pain postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ramsey sedation scores</measure>
    <time_frame>48 h postoperatively</time_frame>
    <description>Sedation score is assessed for safety of epidural analgesic use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequencies of PCA demand</measure>
    <time_frame>48 h postoperatively</time_frame>
    <description>Patient demand will be assessed by PCA demand</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PCA delivery counts</measure>
    <time_frame>48 h postoperatively</time_frame>
    <description>Delivery count shows the actual PCA delivery. It is different from the demand.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total fentanyl consumption</measure>
    <time_frame>48 h postoperatively</time_frame>
    <description>Total analgesic use during the study period</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Hip Fracture</condition>
  <arm_group>
    <arm_group_label>Group I (control)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient controlled analgesia (epidural fentanyl): PCA only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PCA plus lumbar plexus &amp; sciatic nerve transcutaneous electric nerve stimulation (LS-TENS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PCA plus surgical wound transcutaneous electric nerve stimulation ( SW-TENS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous electric nerve stimulation</intervention_name>
    <description>The TENS device will be applied for treatment periods of 30-40 minutes. The electrodes will be connected to the TENS device are stimulated in modulation mode and the parameters will be adjusted as pulse width of 60 Î¼s,frequency of 120 Hz and the stimulation intensity as high as the subject could tolerate.
Electrodes will be placed on either lumbar and sciatic nerve tracing unilaterally or on either side or parallel to the surgical wound.</description>
    <arm_group_label>group II</arm_group_label>
    <arm_group_label>group III</arm_group_label>
    <other_name>Intelect portable TENS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Adult patients will be scheduled for surgery due to hip fracture in
        Mustafa Kemal University Hospital will be included in the study.

        Exclusion Criteria: Patients with a history of opioid analgesic abuse, or sensitivity to
        opioids, and those with clinically significant systemic (cardiovascular, pulmonary,
        hepatic, renal, neurologic etc.) diseases, will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Menekse Oksar, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mustafa Kemal University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Menekse Oksar, M.D.</last_name>
    <phone>+3262291000</phone>
    <phone_ext>3062</phone_ext>
    <email>menekseoksar@mku.edu.tr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mustafa Kemal University Hospital</name>
      <address>
        <city>Hatay</city>
        <zip>31100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Menekse G Oksar, MD</last_name>
      <phone>+3262992900</phone>
      <phone_ext>3062</phone_ext>
      <email>menekseoksar@mku.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Menekse Oksar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Selim Turhanoglu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/10551571</url>
    <description>Use of TENS at mixed (2- and 100-Hz) frequencies of stimulation produced a slightly greater opioid-sparing effect than either low (2-Hz) or high (100 Hz) frequencies alone.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/9249122</url>
    <description>High-TAES (9-12 mA) produced a significant decrease in the PCA opioid requirement and opioid-related side effects after low intraabdominal surgery.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/?term=Transcutaneous+electrical+nevre+stimulation+on+acupoints+reduces+fentanyl+requirement+for+postoperative+pain+relief+after+total+hiparthroplasty+in</url>
    <description>TENS on specific acupoints is an effective and complementary approach to reduce postoperative analgesic requirement in elderly patients after total hip arthroplasty..</description>
  </link>
  <results_reference>
    <citation>Hamza MA, White PF, Ahmed HE, Ghoname EA. Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile. Anesthesiology. 1999 Nov;91(5):1232-8.</citation>
    <PMID>10551571</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang B, Tang J, White PF, Naruse R, Sloninsky A, Kariger R, Gold J, Wender RH. Effect of the intensity of transcutaneous acupoint electrical stimulation on the postoperative analgesic requirement. Anesth Analg. 1997 Aug;85(2):406-13.</citation>
    <PMID>9249122</PMID>
  </results_reference>
  <results_reference>
    <citation>Lan F, Ma YH, Xue JX, Wang TL, Ma DQ. Transcutaneous electrical nerve stimulation on acupoints reduces fentanyl requirement for postoperative pain relief after total hip arthroplasty in elderly patients. Minerva Anestesiol. 2012 Aug;78(8):887-95. Epub 2012 Apr 24.</citation>
    <PMID>22531569</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2015</study_first_submitted>
  <study_first_submitted_qc>December 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mustafa Kemal University</investigator_affiliation>
    <investigator_full_name>MENEKSE OKSAR</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Percutaneous Electric Nerve Stimulation</keyword>
  <keyword>Lumbosacral plexus</keyword>
  <keyword>surgical wound</keyword>
  <keyword>postoperative analgesia</keyword>
  <keyword>transcutaneous electrical stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

